Association Between Triglyceride-Glucose Index and Serum Uric Acid Levels: A Biochemical Study on Anthropometry in Non-Obese Type 2 Diabetes Mellitus Patients
Yu Luo,Jianan Hao,Xiaoyu He,Cuiyu Wang,Hang Zhao,Zhimei Zhang,Liqun Yang,Luping Ren
DOI: https://doi.org/10.2147/DMSO.S387961
2022-11-03
Abstract:Yu Luo, 1 Jianan Hao, 1, 2 Xiaoyu He, 1, 2 Cuiyu Wang, 1 Hang Zhao, 1 Zhimei Zhang, 1 Liqun Yang, 1 Luping Ren 1 1 Endocrinology Department, Hebei General Hospital, Shijiazhuang, People's Republic of China; 2 Graduate School, Hebei Medical University, Shijiazhuang, People's Republic of China Correspondence: Luping Ren, Hebei General Hospital, No. 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China, Tel +18633021149, Fax +86 311 85988406, Email Purpose: The triglyceride–glucose index (TyG) is positively correlated with serum uric acid (SUA) in patients with type 2 diabetes mellitus (T2DM). However, whether this relationship exists in non-obese T2DM patients remains unknown. The study investigated the relationship between TyG and SUA in Chinese non-obese T2DM patients and examined the prognostic value of TyG in hyperuricemia (HUA). Patients and Methods: In total, 719 T2DM patients who were not obese were enrolled from among those who visited the Hebei General Hospital. The patients were categorized into groups according to their SUA levels. The relationship between TyG and clinical parameters was examined through correlation analysis. To consider covariates and examine the independent impact of TyG on HUA, logistic regression was performed. The receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of TyG and homeostasis model assessment of insulin resistance (HOMA-IR) for HUA. Results: The HUA prevalence was 12.10%. TyG was statistically different among the four SUA groups, with lower TyG levels in the Q1, Q2, and Q3 groups than that in the Q4 group. TyG was positively correlated with SUA ( r = 0.176, P < 0.001). Logistic regression exhibited that TyG and SUA were independently correlated (OR = 2.427, 95% CI = 1.134-5.195, P = 0.022) even after adjustment for confounding factors. The ROC curve showed that the predictive value of TyG for HUA was higher than that of HOMA-IR ( AUROC = 0.613, P = 0.001). Conclusion: TyG was positively correlated with SUA in non-obese T2DM patients. TyG may better predict HUA in non-obese T2DM patients than HOMA-IR. Keywords: type 2 diabetes mellitus, insulin resistance, uric acid, hyperuricemia, TyG, HOMA-IR, inflammation In the past decade, the prevalence of both hyperuricemia (HUA) and type 2 diabetes mellitus (T2DM) was increasing, and they are currently major public health concerns globally. 1,2 T2DM is a chronic disease characterized by hyperglycemia with insulin resistance (IR) and relative insulin deficiency. HUA is a state in which serum uric acid (SUA) levels are elevated because of excessive production or insufficient excretion of uric acid (UA). Studies have shown that T2DM is closely related to HUA. 3–6 Both these diseases are associated with chronic inflammation. 7–9 Moreover, IR and obesity are the common risk factors for T2DM and HUA. 10–13 Thus, understanding the relationship of HUA with IR and T2DM may be beneficial for investigating mechanisms underlying T2DM and HUA development. The HUA–IR relationship has been investigated in populations with and without diabetes. 14–16 In 53,477 adults, Tae et al 17 showed that the homeostasis model assessment of IR (HOMA-IR) was independently and positively associated with SUA. In 2016, a meta-analysis of 16 cohort studies on the association between SUA and T2DM revealed that SUA was independently associated with T2DM, and IR developed with an increase in baseline SUA. 18 Inflammation is considered a crucial link in the IR–HUA relationship. 19 SUA may influence insulin signaling and induce IR under the action of inflammatory factors. 20 On the other hand, IR can cause inflammation and indirectly promote HUA. Administration of anti-inflammatory intervention to insulin-resistant individuals reduces SUA levels. 21 Although obese individuals are more likely to have IR and HUA, non-obese individuals, including those normal-weight and overweight, also have elevated SUA levels. 22–24 Currently, few studies have investigated the IR–HUA relationship in non-obese people. Several measurement methods have been used to evaluate IR, with the gold standard being the hyperinsulinemic-euglycemic clamp (HEC) technique. HEC is less used in clinical studies because it is time-consuming, labor-intensive, and invasive. HOMA-IR is the most commonly used clinical surrogate index. HOMA-IR is based on fasting insulin (FINS) and fasting plasma glucose (FPG) levels. HOMA-IR is susceptible to the effect of exogenous insuli -Abstract Truncated-